AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Comera Life Sciences Holdings, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
3.07K
AVG Volume
948
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0200K400K600K800K20212022
CMRA Revenue (USD) by year
PeriodRevenue (USD)
2022633.1K
2021319.83K
Net Income (USD)
-20M-15M-10M-5M020212022
CMRA Net Income (USD) by year
PeriodNet Income (USD)
2022-18M
2021-5.45M
Operating Income (USD)
-15M-10M-5M020212022
CMRA Operating Income (USD) by year
PeriodOperating Income (USD)
2022-11.97M
2021-5.54M
EBITDA (USD)
-20M-15M-10M-5M020212022
CMRA EBITDA (USD) by year
PeriodEBITDA (USD)
2022-17.89M
2021-668.5K
Cash Flows (USD)
-40M-30M-20M-10M020212022
CMRA Cash Flows (USD) by year
PeriodCash Flows (USD)
2022-38.38M
2021-3.9M
EPS (USD)
-2-1.5-1-0.500.520212022
CMRA EPS (USD) by year
PeriodEPS (USD)
2022-1.67
20210.06
Expenses (USD)
020M40M60MR&DSG&ACapex20212022
CMRA Expenses (USD) by year
PeriodExpenses (USD)
202241M
20215.84M
Cash & Debt (USD)
02M4M6M8MCashShort Term Debt20212022
CMRA Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2022446.61K
20216.51M
Debt ratios
0246820212022
CMRA Debt ratios by year
PeriodDebt ratios
20220.09
20216.23
Margins
0%20%40%60%80%20212022
CMRA Margins by year
PeriodMargins
202266.77%
202149.66%
Return on Capital
0%100%200%300%20212022
CMRA Return on Capital by year
PeriodReturn on Capital
2022288.2%
202137.12%
Shares Outstanding
05M10M15M20M20212022
CMRA Shares Outstanding by year
PeriodShares Outstanding
202216.69M
202119.09M
Book Value Per Share (USD)
-0.8-0.6-0.4-0.2-020212022
CMRA Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2022-0.37
2021-0.77
Total Assets (USD)
02M4M6M8M20212022
CMRA Total Assets (USD) by year
PeriodTotal Assets (USD)
20223.73M
20217.42M
Employee Count
0510152022
CMRA Employee Count by year
PeriodEmployee Count
202212
Free Cash Flow Yield
-200000000%-150000000%-100000000%-50000000%0%med -1528873.15%Jan 25May 25Sep 25Jan 26May 26Sep 26
CMRA Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-1528873.15%
Sep 26-1528873.15%
Aug 26-1528873.15%
Aug 26-1528873.15%
Aug 26-1528873.15%
Aug 26-1528873.15%
Jul 26-1528873.1%
Jul 26-1528873.15%
Jul 26-1528873.15%
Jul 26-152887310.29%
Jul 26-1528873.15%
Jun 26-1528873.15%
Jun 26-1528873.15%
Jun 26-1528873.15%
Jun 26-1528873.15%
May 26-1528873.15%
May 26-1528873.15%
May 26-1528873.15%
May 26-1528873.15%
May 26-1528873.15%
Apr 26-1528873.15%
Apr 26-1528873.15%
Apr 26-1528873.15%
Apr 26-1528873.15%
Mar 26-1528873.15%
Mar 26-1528873.15%
Mar 26-1528873.15%
Mar 26-1528873.15%
Feb 26-1528873.15%
Feb 26-1528873.15%
Feb 26-1528873.15%
Feb 26-1528873.1%
Jan 26-1528873.1%
Jan 26-1528873.15%
Jan 26-1528873.15%
Jan 26-1528873.15%
Jan 26-1528873.15%
Dec 25-1528873.15%
Dec 25-1528873.15%
Dec 25-1528873.15%
Dec 25-1528873.15%
Nov 25-1528873.1%
Nov 25-1528873.15%
Nov 25-1528873.1%
Nov 25-1528873.15%
Oct 25-1528873.1%
Oct 25-1528873.15%
Oct 25-1528873.15%
Oct 25-1528873.15%
Oct 25-1528873.15%
Sep 25-1528873.15%
Sep 25-764436.55%
Sep 25-764436.57%
Sep 25-764436.57%
Aug 25-764436.57%
Aug 25-764436.57%
Aug 25-764436.57%
Aug 25-764436.57%
Aug 25-764436.57%
Jul 25-764436.57%
Jul 25-764436.57%
Jul 25-764436.57%
Jul 25-764436.57%
Jun 25-764436.57%
Jun 25-764436.57%
Jun 25-764436.57%
Jun 25-764436.57%
May 25-764436.57%
May 25-1528873.15%
May 25-1528873.15%
May 25-1528873.1%
May 25-1528873.15%
Apr 25-764436.57%
Apr 25-764436.57%
Apr 25-764436.57%
Apr 25-764436.57%
Mar 25-764436.57%
Mar 25-764436.57%
Mar 25-764436.57%
Mar 25-764436.55%
Feb 25-764436.57%
Feb 25-764436.57%
Feb 25-764436.57%
Feb 25-764436.55%
Jan 25-764436.57%
Jan 25-764436.57%
Jan 25-764436.57%
Jan 25-764436.57%
Jan 25-764436.55%
Dec 24-764436.55%
Dec 24-1528873.15%
Dec 24-1528873.1%
Dec 24-1528873.15%
Nov 24-764436.57%
Nov 24-509624.34%
Nov 24-1528873.15%
Nov 24-1528873.15%
Nov 24-1528873.15%
Oct 24-764436.55%
Oct 24-15288.73%
Price to Sales
00.10.20.3med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CMRA Price to Sales by year
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240.01
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240.23
Price to Book
02505007501000med 436.83Jul 21Aug 21Sep 21Dec 21Jan 22Feb 22Mar 22
CMRA Price to Book by year
PeriodPrice to Book
Mar 221.98
Mar 221.98
Mar 221.98
Mar 221.98
Feb 221.97
Feb 221.97
Feb 221.97
Feb 221.97
Jan 221.97
Jan 221.97
Jan 221.97
Jan 221.97
Dec 211.97
Sep 21876.9
Sep 21876.03
Sep 21872.54
Sep 21871.67
Aug 21871.67
Aug 21873.42
Aug 21875.16
Aug 21875.16
Jul 21873.42
Jul 21871.67
Jul 21875.16
Jul 21873.42
Jul 21874.29
Comera Life Sciences Holdings, Inc.
CMRA
Stockpicker

Video analysis: CMRA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.